NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Aptorum Group Limited (NASDAQ: APM)
APM Technical Analysis
2
As on 3rd Jan 2025 APM STOCK Price closed @ 2.14 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.28 & Buy for SHORT-TERM with Stoploss of 2.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
APMSTOCK Price
Open | 2.19 | Change | Price | % |
High | 2.39 | 1 Day | -0.06 | -2.73 |
Low | 2.00 | 1 Week | 1.41 | 193.15 |
Close | 2.14 | 1 Month | 1.41 | 193.15 |
Volume | 1940568 | 1 Year | -0.10 | -4.46 |
52 Week High 10.55 | 52 Week Low 0.55 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
FCUV | 0.96 | 174.29% |
NVDA | 144.47 | 4.45% |
QSI | 4.29 | 0.70% |
CRNC | 19.33 | 143.76% |
LMDX | 0.02 | 0.00% |
CYCC | 0.46 | 24.32% |
LCID | 3.29 | 8.58% |
TNXP | 0.31 | 0.00% |
AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
APM Daily Charts |
APM Intraday Charts |
Whats New @ Bazaartrend |
APM Free Analysis |
|
APM Important Levels Intraday
RESISTANCE | 2.89 |
RESISTANCE | 2.65 |
RESISTANCE | 2.50 |
RESISTANCE | 2.35 |
SUPPORT | 1.93 |
SUPPORT | 1.78 |
SUPPORT | 1.63 |
SUPPORT | 1.39 |
APM Forecast January 2025
4th UP Forecast | 4.47 |
3rd UP Forecast | 3.72 |
2nd UP Forecast | 3.26 |
1st UP Forecast | 2.8 |
1st DOWN Forecast | 1.48 |
2nd DOWN Forecast | 1.02 |
3rd DOWN Forecast | 0.56 |
4th DOWN Forecast | -0.19 |
APM Weekly Forecast
4th UP Forecast | 2.64 |
3rd UP Forecast | 2.48 |
2nd UP Forecast | 2.38 |
1st UP Forecast | 2.28 |
1st DOWN Forecast | 2.00 |
2nd DOWN Forecast | 1.90 |
3rd DOWN Forecast | 1.80 |
4th DOWN Forecast | 1.64 |
APM Forecast2025
4th UP Forecast | 34.96 |
3rd UP Forecast | 24.43 |
2nd UP Forecast | 17.93 |
1st UP Forecast | 11.42 |
1st DOWN Forecast | -7.14 |
2nd DOWN Forecast | -13.65 |
3rd DOWN Forecast | -20.15 |
4th DOWN Forecast | -30.68 |
Aptorum Group Limited ( NASDAQ USA Symbol : APM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
APM Other Details
Segment | EQ | |
Market Capital | 86929392.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
APM Address
APM Latest News
APM Business Profile
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Address: 17 Hanover Square, London, United Kingdom, W1S 1BN
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service